相关实验视频
Updated: Jan 9, 2026

08:19
In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
Published on: June 22, 2020
7.0K
提丁心肌病,新兴证据:不仅仅是一个大心脏
Federico Angriman1,2, Francesca Bortolotti2,3, Maria Perotto1,2
1Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy.
Current cardiology reports
|December 2, 2025
概括
蒂相关心肌病 (TTN CMP) 是扩张性心肌病 (DCM) 的常见遗传原因,表现出各种症状. 最近的研究澄清了它的遗传基础,分子机制和临床谱,有助于诊断和向治疗.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
- 遗传流行病学遗传流行病学
背景情况:
- 提丁相关心肌病 (TTN CMP) 是扩张性心肌病 (DCM) 的主要遗传原因.
- TTN CMP的临床表现和透性高度可变,使风险分层复杂化.
- 了解TTN CMP异质性对于有效管理至关重要.
研究的目的:
- 审查最近在TTN CMP的遗传,分子和临床理解方面的进展.
- 突出TTN CMP的异质性及其对诊断和治疗的影响.
- 讨论关于TTN-CMP病理生理学和治疗策略的新兴见解.
主要方法:
- 对TTN CMP遗传学,分子机制和临床表现的当前文献的综述.
- 从患者衍生的诱导多能干细胞 (iPSC) 模型中分析数据.
- 综合了先进的心脏成像研究的发现.
主要成果:
- 丁丁切断变体 (TTNtv) 与DCM有关,但也在健康个体中发现,需要仔细解释.
- 机制包括哈普洛不足和有毒的功能获取,受变异位置的影响.
- TTN CMP表现出广泛的表型范围,从无症状携带者到末期心力衰竭,结果各不相同.
- 来自患者的iPSC模型和成像研究揭示了病理生理路径和潜在的治疗点.
结论:
- TTN CMP是一种遗传复杂和表型多样化的疾病.
- 对遗传和分子基础的更好理解对于准确的诊断和预后至关重要.
- 新型实验模型和先进的成像技术为TTN CMP的有针对性的治疗干预提供了有希望的途径.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Cardiomyopathy II: Dilated Cardiomyopathy
447
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447
Cardiomyopathy IV: Restrictive Cardiomyopathy
431
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
431
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Mitral Stenosis II: Clinical features and Diagnostic Tests
196
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
196

